8HG-32662-54912
3 vaccinations
7 coded responses
36 check-ins
7 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 222 / VA
- Registered
- 2021-04-13
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Registered dependents
MAK-15529-97478
Child or adolescent in my care · Female · 2022-06-30
Timeline
-
2021-04-13
Registered in v-safe
-
2021-04-13
Dose 1 — Moderna
- 2021-04-13
- 2021-04-14
- 2021-04-15
- 2021-04-16
- 2021-04-17
- 2021-04-18
- 2021-04-19
- 2021-04-20
- 2021-04-27
- 2021-05-04
-
2021-05-11
Dose 2 — Moderna
- 2021-05-11
-
2021-05-12
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain, Swelling · Muscle or body aches, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activitiesAdult check-in
- 2021-05-13
- 2021-05-14
- 2021-05-15
- 2021-05-16
- 2021-05-17
- 2021-05-18
- 2021-05-25
- 2021-06-01
- 2021-06-08
-
2021-06-15
Survey response — day 35, dose 2MedDRA: Nasopharyngitis, Productive cough, Respiratory tract congestion — Feeling: GoodFree text: Common cold (congestion mostly with mild wet cough)MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-06-22
-
2021-08-10
Survey response — 3 months, dose 2MedDRA: Migraine — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Migraine headacheMedDRA releases: 2021-09,2024-11 · check-in free text available
-
2021-11-09
Survey response — 6 months, dose 2MedDRA: Migraine, Nasopharyngitis — Feeling: FairFree text: Cold (blowing nose), migraineMedDRA releases: 2024-11 · check-in free text available
-
2021-11-29
Dose 3 — Moderna
- 2021-12-02
-
2021-12-04
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Headache, Fatigue or tirednessAdult check-in
- 2021-12-05
-
2021-12-06
Survey response — day 7, dose 3MedDRA: Rhinorrhoea — Feeling: GoodFree text: Runny noseMedDRA releases: 2024-11 · check-in free text available
- 2021-12-13
-
2021-12-20
Survey response — day 21, dose 3MedDRA: Headache, Migraine — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Headache, migraineMedDRA releases: 2024-11 · check-in free text available
- 2021-12-27
- 2022-01-03
-
2022-01-10
Survey response — day 42, dose 3MedDRA: Migraine — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: MigraineMedDRA releases: 2024-11 · check-in free text available
-
2022-02-28
Survey response — 3 months, dose 3MedDRA: Vomiting — Feeling: Good · Be unable to do your normal daily activitiesFree text: VomitingMedDRA releases: 2024-11 · check-in free text available
- 2022-05-30
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-04-13 | Moderna | |
| 2 | 2021-05-11 | Moderna | |
| 3 | 2021-11-29 | Moderna | No |
Free text
Release 9 — day 35, dose 2
Symptoms: Common cold (congestion mostly with mild wet cough)
Release 9 — 3 months, dose 2
Symptoms: Migraine headache
Release 10 — 6 months, dose 2
Symptoms: Cold (blowing nose), migraine
Release 10 — day 7, dose 3
Systemic reaction (other): Runny nose
Release 10 — day 21, dose 3
Symptoms: Headache, migraine
Release 10 — day 42, dose 3
Symptoms: Migraine
Release 11 — 3 months, dose 3
Symptoms: Vomiting
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Headache | · | · | ✓ |
| SD | Migraine | ✓ | · | ✓ |
| SD | Nasopharyngitis | ✓ | ✓ | ✓ |
| SD | Productive cough | ✓ | ✓ | ✓ |
| SD | Respiratory tract congestion | ✓ | ✓ | ✓ |
| SD | Vomiting | · | · | ✓ |
| SRO | Rhinorrhoea | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release